ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 127 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,412,739 | +1020.7% | 133,571 | +1158.0% | 0.00% | – |
| Q2 2023 | $304,524 | +28.5% | 10,618 | +7.4% | 0.00% | – |
| Q1 2023 | $236,920 | -44.9% | 9,884 | -61.0% | 0.00% | – |
| Q4 2022 | $429,869 | +9.9% | 25,346 | -3.8% | 0.00% | – |
| Q3 2022 | $391,000 | -5.1% | 26,334 | +0.7% | 0.00% | – |
| Q2 2022 | $412,000 | -29.7% | 26,157 | +20.3% | 0.00% | – |
| Q1 2022 | $586,000 | +91.5% | 21,740 | +163.0% | 0.00% | – |
| Q4 2021 | $306,000 | -33.3% | 8,267 | -13.8% | 0.00% | – |
| Q3 2021 | $459,000 | +55.6% | 9,593 | +9.6% | 0.00% | – |
| Q2 2021 | $295,000 | +26.1% | 8,754 | +54.3% | 0.00% | – |
| Q1 2021 | $234,000 | -35.4% | 5,675 | -32.6% | 0.00% | – |
| Q3 2020 | $362,000 | -96.5% | 8,414 | -96.2% | 0.00% | -100.0% |
| Q2 2020 | $10,325,000 | – | 220,904 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |